Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4
InChiKey: SWMDAPWAQQTBOG-UHFFFAOYSA-N
The research results suggest that the lowering of elevated levels of plasma Trx-1 in cancer patients may provide a surrogate for the inhibition of tumor Trx-1 by PX-12
GLPG0187 demonstrates a dose-dependent significant reduction in tumour cell migration
2-benzothiazin-4-yl}oxy)ethyl carbonate
LY2606368 - CAS# 1234015-52-1 ine maleate Activin receptor-like kinase5 inhibition suppressesPrexasertib, also know LY2606368, is a n inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity. Upon administration, LY2606368 selectively binds to chk1, thereby preventing activity of chk1 and abrogating the repair of damaged DNA. This may lead to an accumulation of damaged DNA and may promote genomic instability and apoptosis. LY2606368 may potentiate the cytotoxicity of DNA damaging agents and reverse tumor cell resistance